VICARIOUS SURGICAL INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
VICARIOUS SURGICAL INC. (RBOT) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$7.17 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-03-09
- VICARIOUS SURGICAL INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$7.14M.
- VICARIOUS SURGICAL INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$14.60M.
- VICARIOUS SURGICAL INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$62.13M.
- VICARIOUS SURGICAL INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-03-31 was -$16.61M.
- VICARIOUS SURGICAL INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$7.17M.
- VICARIOUS SURGICAL INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$43.09M.
- VICARIOUS SURGICAL INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$63.39M.
- VICARIOUS SURGICAL INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$57.42M, a 136.44% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 5 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 8 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$7.17M 10-K · filed 2026-03-09 | |||||||
| 2025-09-30 | -$6.57M 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | -$5.83M 10-Q · filed 2025-08-12 | |||||||
| 2025-03-31 | -$7.14M 10-Q · filed 2025-05-12 | |||||||
| 2024-12-31 | -$43.09M 10-K · filed 2026-03-09 | |||||||
| 2024-09-30 | -$45.75M 10-Q · filed 2025-11-12 | |||||||
| 2024-06-30 | -$32.57M 10-Q · filed 2025-08-12 | |||||||
| 2024-03-31 | -$14.60M 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | -$63.39M 10-K · filed 2025-03-17 | |||||||
| 2023-09-30 | -$57.09M 10-Q · filed 2024-11-12 | |||||||
| 2023-06-30 | -$83.40M 10-Q · filed 2024-08-13 | |||||||
| 2023-03-31 | -$62.13M 10-Q · filed 2024-04-29 | |||||||
| 2022-12-31 | -$57.42M 10-K · filed 2024-03-04 | |||||||
| 2022-09-30 | -$46.83M 10-Q · filed 2023-11-13 | |||||||
| 2022-06-30 | -$32.31M 10-Q · filed 2023-07-28 | |||||||
| 2022-03-31 | -$16.61M 10-Q · filed 2023-05-08 | |||||||
| 2021-12-31 | $157.58M 10-K · filed 2023-02-15 | |||||||
| 2021-09-30 | $168.68M 10-Q · filed 2022-11-07 | |||||||
| 2021-06-30 | -$8.66M 10-Q · filed 2022-08-08 | -$861.20K 10-Q · filed 2021-08-12 | ||||||
| 2021-03-31 | -$2.72M 10-Q · filed 2022-05-09 | -$69.35K 10-Q · filed 2021-05-24 | ||||||
| 2020-12-31 | $1.10M 10-K/A · filed 2021-05-24 | $14.68M 10-K · filed 2022-03-31 | ||||||
| 2020-09-30 | $1.18M 10-Q · filed 2020-11-13 | $18.12M 10-Q/A · filed 2022-03-31 |